MCM
PFE icon

Matarin Capital Management’s Pfizer PFE Stock Holding History

Matarin Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-44,677
Closed -$1.84M – 262
2019
Q2 		$1.84M Sell
44,677
-11,049
-20% -$439K 0.13% 182
2019
Q1 		$2.25M Sell
55,726
-37
-0.1% -$1.48K 0.16% 165
2018
Q4 		$2.31M Buy
55,763
+15,486
+38% +$643K 0.19% 167
2018
Q3 		$1.68M Buy
+40,277
New +$1.55M 0.11% 187

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Matarin Capital Management's PFE Position: Q3 2019 in Review

Matarin Capital Management sold out of Pfizer (PFE) in Q3 2019, closing a stake of 44,677 shares — an estimated $1.84M sold.

Matarin Capital Management first reported a position in PFE in Q3 2018 and held it in 4 quarters. The position peaked at $2.31M in Q4 2018. 2,322 funds tracked by Wall St. Rank hold PFE as of Q3 2019.

  • Matarin Capital Management reported no remaining Pfizer position as of Q3 2019 after selling out during the quarter.
  • Matarin Capital Management sold 44,677 Pfizer shares in Q3 2019, an estimated $1.84M.
  • Matarin Capital Management first reported a position in Pfizer in Q3 2018 and held it in 4 quarters.
  • Matarin Capital Management's Pfizer position peaked at $2.31M in Q4 2018.
  • 2,322 funds tracked by Wall St. Rank held Pfizer as of Q3 2019.

Based on Matarin Capital Management's 13F filing for Q3 2019, filed 5 Nov 2019.